1.Ifosfamide and Etoposide in Relapsed Refractory Childhood Acute Lymphoblastic Leukemia.
Shung Shin KIM ; Bin CHO ; Dae Chul JEONG ; Hack Ki KIM
Korean Journal of Pediatric Hematology-Oncology 1997;4(1):90-97
BACKGROUND: The prognosis for children with relapsed acute lymphoblastic leukemia remains dismal. Ifosfamide has previously been shown to be active as a single agent and in combination with doxorubicin, etoposide, and teniposide in pediatric solid tumors, recurrent acute lymphoblastic leukemia and adult acute leukemia. We assessed the efficacy and the toxicity of the drug combination with ifosfamide and etoposide in patients with relapsed refractory acute lymphoblastic leukemia. METHODS: Between April 1995 and May 1996, twenty children aged 1 to 14 years with ALL in Catholic Medical Center, all heavily pretreated and in bone marrow relapse, were enrolled in this study. Drugs were given intravenously each day for 5 days at the following doses ; ifosfamide 1.8 g/m2/day, etoposide 100 mg/m2/day and mesna 1440 mg/ m2/day(as a uroprotectant) ; Cycles were repeated every 28 days for two cycles. RESULTS: 1) Twenty heavily pretreated patients were entered on study. At study entry, seventeen patients were in first relapse, two were in second relapse and one was in third relapse. 2) Six patients(30%) achieved complete remission, and eight patients(40%) achieved partial remission. Overall response rate was 70%. 3) Duration of remission ranged from 30 days to 230 days. 4) The toxicity of the regimen was tolerated. Moderate or severe toxicity evaluated on a per cycle basis included : neutropenia 52.5%, thrombocytopenia 45%, hemorrhagic cystitis 12.5% and mucositis 2.5%. 5) Two patients went on to bone marrow transplantation with histocompatibility matched sibling donors while in remission. CONCLUSION: The combination of ifosfamide and etoposide with mesna uroprotection has significant activity in relapsed refractory childhood lymphoblastic leukemia with tolerable toxicity. We recommended bone marrow transplantation after successful reinduction because of short remission duration of this regimen.
Adult
;
Bone Marrow
;
Bone Marrow Transplantation
;
Child
;
Cystitis
;
Doxorubicin
;
Etoposide*
;
Histocompatibility
;
Humans
;
Ifosfamide*
;
Leukemia
;
Mesna
;
Mucositis
;
Neutropenia
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
;
Prognosis
;
Recurrence
;
Siblings
;
Teniposide
;
Thrombocytopenia
;
Tissue Donors
2.A Case of Transient Neonatal Hypothyroidism Due to Maternal TSH-Binding Inhibitor Immunoglobulins.
Shung Shin KIM ; Moon Young SONG ; Byung Kyu SHU ; Byung Churl LEE
Journal of Korean Society of Pediatric Endocrinology 1998;3(1):84-89
Recognition of transient forms of neonatal hypothyroidism is very important to prevent the complications of congenital hypothyroidism. Transplacental passage of TSH-binding inhibitory immunoglobulins(TBII) may result in transient congenital hypothyroidism. Transient neonatal hypothyroidism was found in a daughter of 25-yr-old mother who was receiving levothyroxine for primary hypothyroidism due to Hashimoto's thyroiditis. The neonate was treated with thyroxine which was discontinued at 24 months of age. Thyroid scanning during the neonatal period failed to identify functional thyroid tissue, suggesting thyroid agenesis, whereas thyroid scan performed on subsequent follow-up revealed a normal gland. Sequential measurements of serum autoantibodies directed towards the TSH receptor were made in the patient and her mother. High titers of blocking antibodies were present in the mother(TBII, 82.1%) and newborn(TBII, 85.5%) at 19 days after birth. The levels remained persistently high in the mother, whereas they declined and undetectable in the patient at 23 months of age. The above laboratory and clinical data were compatible with blocking nature of TBII, resulting in transient neonatal hypothyroidism and an athyreotic appearance on scan. The TBII measurement can be a useful predictor of neonatal hypothyroidism as well as confirming the nature of the disease in newborn.
Antibodies, Blocking
;
Autoantibodies
;
Congenital Hypothyroidism
;
Follow-Up Studies
;
Humans
;
Hypothyroidism*
;
Immunoglobulins*
;
Infant, Newborn
;
Mothers
;
Nuclear Family
;
Parturition
;
Receptors, Thyrotropin
;
Thyroid Dysgenesis
;
Thyroid Gland
;
Thyroiditis
;
Thyroxine
3.The Effects of Physostigmine on Arousal after Laryngomicroscopic surgery.
Jin Ock KIM ; Jong Seok LEE ; Shung Euy SHIN ; Jin Soo KIM ; Yong Taek NAM
Korean Journal of Anesthesiology 1993;26(6):1200-1206
Physostigmine has been used to counteract somnolence or coma induced by different types of phamacological agent, such as anticholinergics, opioids, ketamine and tricyclic antidepressants. In this study, we have assesed the effects of physostigmine on arousal after laryngomicroscopic surgery under enflurane-N2O general anesthesia and the effects of muscle relaxants. Forty patients were divided randomly into four groups such as I (succinylcholine only), II (vecuronium only), III(succinylcholine and physostigmine) and IV(vecuronium and physostigmine). Physostigmine 1mg was administered intravenously at the end of operation. We evaluated the recovery time of spontaneous respiration, gag reflex, pain response, extubation, eye opening on command and orientation after the end of operation. We also observed the end tidal CO2 and expired enflurane concentration with SARA(R) spectrometry at the end of operation and at the time of each recovery parameters returned . Our results revealed that physostigmine groups(group III and IV) were recovered more rapidly in the recovery time of eye opening to verbal command and orientation than non-physostigmine groups(group I and II ). But there was no difference in recovery time of spontaneous respiration, gag reflex, pain response and extubation. Therefore, we concluded that physostigmine 1 mg, i.v. has the effects of early arousal after short and deep general anesthesia and it did not show any specific complications such as bradycardia, bronchospasm, nausea and vomiting.
Analgesics, Opioid
;
Anesthesia, General
;
Antidepressive Agents, Tricyclic
;
Arousal*
;
Bradycardia
;
Bronchial Spasm
;
Cholinergic Antagonists
;
Coma
;
Enflurane
;
Equidae
;
Humans
;
Ketamine
;
Nausea
;
Physostigmine*
;
Reflex
;
Respiration
;
Spectrum Analysis
;
Vomiting
4.Effect of Lovastatin on Serum Lipids in Primary Hypercholesterolemia.
Wee Hyun PARK ; Shin Woo KIM ; Eon Jo WOO ; Seung Wan KANG ; Jin Yong HWANG ; Shung Chull CHAE ; Jae Eun JUN
Korean Circulation Journal 1991;21(2):322-327
10 Patients with primary hypercholesterolemia were treated for 12 weeks with lovastation(20mg t.i.d). Lovastatin reduced mean total and low density lipoprotein cholesterol by 43% and 57% respectively(p<0.001). High density lipoprotein cholesterol and triglyceride levels were unchanged by the drug. Adverse effects attributable to lovastatin were not observed. Thus lovastatin is considered as an effective lipid lowering agent for the treatment of primary moderate hypercholesterolemia.
Cholesterol, HDL
;
Cholesterol, LDL
;
Humans
;
Hypercholesterolemia*
;
Lovastatin*
;
Triglycerides
5.Low Resistin Level is Associated with Poor Hospitalization-Free Survival in Hemodialysis Patients.
Wookyung CHUNG ; Eul Sik JUNG ; Dongsu SHIN ; Shung Han CHOI ; Ji Yong JUNG ; Jae Hyun CHANG ; Hyun Hee LEE ; Dong Ki KIM ; Sejoong KIM
Journal of Korean Medical Science 2012;27(4):377-381
Malnutrition and inflammation are related to high rates of morbidity and mortality in hemodialysis patients. Resistin is associated with nutrition and inflammation. We attempted to determine whether resistin levels may predict clinical outcomes in hemodialysis patients. We conducted a prospective evaluation of 100 outpatients on hemodialysis in a single dialysis center (male, 46%; mean age, 53.7 +/- 16.4 yr). We stratified the patients into 4 groups according to quartiles of serum resistin levels. During the 18-month observational period, patients with the lowest quartile of serum resistin levels had poor hospitalization-free survival (log rank test, P = 0.016). After adjustment of all co-variables, patients with the lowest quartile of serum resistin levels had poor hospitalization-free survival, compared with reference resistin levels. Higher levels of interleukin-6 were an independent predictor of poor hospitalization-free survival. In contrast, serum resistin levels were not correlated with interleukin-6 levels. The current data showed that low resistin levels may independently predict poor hospitalization free survival in hemodialysis patients.
Adult
;
Aged
;
Diabetes Complications
;
Female
;
Hospitalization
;
Humans
;
Interleukin-6/blood
;
Kidney Failure, Chronic/blood/*mortality
;
Male
;
Middle Aged
;
Proportional Hazards Models
;
Prospective Studies
;
*Renal Dialysis
;
Resistin/*blood
;
Survival Analysis
6.The Changes of Incidence of Nosocomial Sepsis, and Risk Factors in Extremely Low Birth Weight Infants.
Bong Lim KIM ; Jong Hee WHANG ; Chang Kyu KANG ; Je Won SIM ; Shung Shin KIM ; Yun Sil CHANG ; Won Soon PARK ; Eung Sang CHOI
Journal of the Korean Society of Neonatology 2002;9(1):12-20
PURPOSE: To know whether the changes in the risk factors of nosocomial sepsis had an impact on the occurrence of nosocomial sepsis (NS) in extremely low birth weight infants (ELBW I). METHODS: ELBW I who were admitted to the NICU at Samsung Medical Center from October 1994 to December 2000 were devided into three groups according to periods (period I:1994.10-1996.9, period II:1996.10-1998.12, period III:1999.1-2000.12), and charts were reviewed retrospectively for demographic profile, incidence of NS, and changing patterns of risk factors of NS. RESULTS: Gestational age and birth weight of ELBW I decreased and the incidence of NS increased significantly during third period. However, cumulative incidence of NS corrected by hospital days was not changed irrespective of periods. Among the risk factors of NS in 3rd period, use of antibiotics in the 1st day, postnatal dexamethasone and use and duration of indwelling umbilical catheters decreased significantly and the use of nasal continuous positive airway pressure increased significantly especially, in ELBW I under 800 g of birth weight. In the ELBW I under 800 g of birth weight, cumulative incidence of NS and mortality among the infants who suffered from NS decreased significantly in 3rd period. CONCLUSION: Efforts to decrease the risk factors of NS can prevent the increase in incidence of NS in ELBW I.
Anti-Bacterial Agents
;
Birth Weight
;
Catheters
;
Continuous Positive Airway Pressure
;
Dexamethasone
;
Gestational Age
;
Humans
;
Incidence*
;
Infant*
;
Infant, Extremely Low Birth Weight
;
Infant, Low Birth Weight*
;
Infant, Newborn
;
Mortality
;
Retrospective Studies
;
Risk Factors*
;
Sepsis*
7.Short-term prognostic value of CRP in the patients with acute coronary syndrome.
Tae Ik KIM ; Shung Chull CHAE ; Dong Hun YANG ; Seong Chull SHIN ; Ho Sang BAE ; Dong Hun KWAK ; Jong Hyun HWANG ; Yong Geun CHO ; Jae Eun JUN ; Wee Hyun PARK
Korean Circulation Journal 2000;30(11):1387-1394
BACKGROUND AND OBJECTIVES: Acute coronary syndrome occurs most commonly in the setting of atherosclerotic coronary artery disease, but there is little information concerning the mechanism responsible for the transition from stable to unstable coronary atherosclerotic plaque. Hypothetically, several microorganism(Chlamydia pneumonia, Cytomegalovirus and Helicobacter pylori) and their inflammatory reaction have been suggested as a causative motive in progression of acute coronary syndrome. Although it is unclear whether the serum level of CRP as a inflammatory parameter is concerned with previous inflammatory change or myocardial necrosis, CRP apper to be predictive of higher risk for cardiac event in the patients with acute coronary syndrome. Our objective was to evaluate whether the inflammatory parameters(CRP, ESR and WBC count) is useful in predicting the short-term cardiac risk within 30 days. MATERIALS AND METHOD: One hundred and ten patients with acute coronary syndrome were enrolled from April 1998 through August 1998. Blood samples were collected at 1st hour, 24th hour, 48th hour and 7th day and tested for CRP, ESR, WBC count and CK-MB level. Values of 323 normal were used as control. All patients were followed up for 30 days and assessed for the presence of cardiac complications. RESULTS: Peak CRP value of the patients with acute myocardial infarction(3.4+/-3.85 mg/dL, n=2) was higher than that of the patients with unstable angina(0.7+/-0.93 mg/dL, n=8, p<0.05) and controls(0.3+/-0.48 mg/dL, n=23, p<0.05). Peak CRP value of patients with cardiac complication was higher than that of patients without complication(7.7+/-4.77 mg/dL, n=5 vs 1.3+/-1.74 mg/dL, n=5 ; p<0.05). In multivariate analysis, peak CRP value was the only predictive parameter for development of cardiac complications in the patients with acute coronary syndrome(Odds ratio 4.893, 95% confidence interval 1.212-19.756, p value=.026). In the high-CRP group(>2 mg/dL, n=0), the cardiac complication rate was higher than the low-CRP group(< or =2 mg/dL, n=0) (43.3% vs 2.5%, p<0.05). Peak CRP value was correlated with age(r=.191, p=.045), pulse rate(r=.186, p=.008), left ventricular ejection fraction(r=0.384, p<0.001), peak ESR(r=.383, p<0.001) and peak WBC count(r=.307, p=.001), but not with peak CK-MB level. CONCLUSION: Elevated CRP level in patients with acute coronary syndrome seems to be a valuable prognostic factor for the development of cardiac complications within 1 month after admission.
Acute Coronary Syndrome*
;
Coronary Artery Disease
;
Cytomegalovirus
;
Helicobacter
;
Humans
;
Multivariate Analysis
;
Necrosis
;
Plaque, Atherosclerotic
;
Pneumonia
8.Association Between Gamma-Glutamyltransferase and Hypertension Incidence in Rural Prehypertensive Adults.
Jun Hyun HWANG ; Ji Yeon SHIN ; Byung yeol CHUN ; Duk Hee LEE ; Keon Yeop KIM ; Wee hyun PARK ; Shung chull CHAE
Journal of Preventive Medicine and Public Health 2010;43(1):18-25
OBJECTIVES: Prehypertension is associated with a higher risk of developing hypertension compared with normotension. Yet, factors predicting the development of hypertension among prehypertensive people are ill-understood. This prospective cohort study was performed to examine if serum gamma-glutamyltrasferase (GGT) within a normal range can predict the future risk of hypertension among prehypertensive adults. METHODS: Study subjects were 293 prehypertensive persons >30-years-of-age who participated in a community-based health survey in 2003 and who were followed up in 2008. Sex-specific quartiles of baseline serum GGT were used to examine association with 5-year hypertension incidence. RESULTS: Baseline serum GGT within normal range predicted the risk of developing hypertension for 5 years only in prehypertensive women. Adjusted relative risks were 1.0, 3.7, 3.6, and 6.0 according to quartiles of baseline serum GGT (P for trend <0.01). This pattern was similarly observed in non-drinkers. However, serum GGT was not associated with incident hypertension in men. Different from serum GGT, baseline serum alanine aminotransferase, another well-known liver enzyme, did not predict the risk of incident hypertension in both genders. CONCLUSIONS: Even though baseline serum GGT within normal range strongly predicted the future risk of hypertension, it was observed only in women, Although underlying mechanisms of this association are currently unclear, serum GGT can be used to select a high risk group of hypertension in prehypertensive women.
9.Volume Control by Using the Body Composition Monitor in a Puerperal Patient on Hemodialysis.
Wookyung CHUNG ; Shung Han CHOI ; Jiyoon SUNG ; Eul Sik JUNG ; Dong Su SHIN ; Ji Yong JUNG ; Jae Hyun CHANG ; Hyun Hee LEE ; Seung Ho LEE ; Sejoong KIM
Electrolytes & Blood Pressure 2011;9(2):63-66
Accurate measurement of the volume status in hemodialysis patients is important as it can affect mortality. However, no studies have been conducted regarding volume management in cases where a sudden change of body fluid occurs, such as during puerperium in hemodialysis patients. This report presents a case in which the patient was monitored for her body composition and her volume status was controlled using a body composition monitor (BCM) during the puerperal period. This case suggests that using a BCM for volume management may help maintain hemodynamic stability in patients with a rapidly changing volume status for a short term period, such as during puerperium.
Body Composition
;
Body Fluids
;
Hemodynamics
;
Humans
;
Organothiophosphorus Compounds
;
Postpartum Period
;
Renal Dialysis
10.On-Line Assessment of Left Ventricular Cavity Area and Function by Automatic Border Detection Echocardiography.
Bong Ryeol LEE ; Eui Ryong CHEONG ; Jae Kean RYU ; Jong Hyeon HWANG ; Hyeon Ju LIM ; Heon Sik PARK ; Shin Woo KIM ; Shung Chull CHAE ; Jae Eun JUN ; Wee Hyeon PARK
Korean Circulation Journal 1994;24(3):380-388
BACKGROUND: Assessment of left ventricular function with conventional 2-dimensional echocardiography (2D echo) remains largely qualitative and subjective because the manual tracing of endocardial borders is laborious and tedious. An automatic border detection (ABD) echo has been recently developed that permits real-time measurements of chamber areas and cardiac function. METHODS: To determine usefulness of ABD echo, left ventricular cross-sectional areas were automatically measured from the parasternal short-axis image in 25 cases including 9 cardiac patients, and compared with those by off-line analysis of the conventional 2D echo image. RESULTS: In on-line ABD analysis, short axis end-diastolic area averaged 13.1+/-2.2cm2, end-systolic area 5.3+/-1.3cm2 and fractional area change 59.4+/-9.0% and off-line manual analysis yielded corresponding values of 14.7+/-2.5cm2, 6.2+/-1.3cm2, and 57.1+/-7.1%. The end-diastolic and end-systolic areas by both methods were significantly different, respectively. Left ventricular end-diastolic and end-systolic area and fractional area change obtained from ABD echo correlated significantly with those of off-line measurements(r=0.897, p<0.001 ; r=0.505, p<0.01 ; r=0.427, p<0.05). CONCLUSION: Thus, these facts suggest that ABD echo is useful for on-line continuous measurement of chamber areas and cardiac function.
Axis, Cervical Vertebra
;
Echocardiography*
;
Humans
;
Ventricular Function, Left